Breast cancer breakthrough as scientists discover faulty gene linked to half of all cases

	Tweet

Scientists announced a major breakthrough in the battle against breast cancer yesterday after discovering a faulty gene involved in half of all cases of the disease which kills 12,000 women in the UK every year.

The gene - called NRG1 - is also implicated in 50 per cent of bowel and prostate cancers and a quarter of cancers of the ovary and bladder.

Cancer charities hailed the find as a ‘major step forward’ and one of the most important developments in cancer gene research in the last 20 years.

Dr Paul Edwards, of the department of pathology at the University of Cambridge, who discovered the faulty gene, said it provided ‘vital information’ about how some cancers spread. The fault does not appear to be hereditary and is not passed on from parents to children.

On its own, the discovery is unlikely to lead to new types of drugs or treatments for cancers. But scientists hope it will give them a much greater understanding of how healthy cells turn bad and how some cancers can be stopped in their tracks.

NRG1 is a tumour suppressor gene. It regulates and controls cells and orders them to ‘commit suicide’ if their DNA becomes seriously damaged. If NRG1 is faulty, cells are more likely to divide uncontrollably and become cancerous.

Dr Edwards said: ‘I believe NRG1 could be the most important tumour suppressor gene discovery in the last 20 years as it gives us vital information about a new mechanism that causes breast cancer.’

The gene is found on chromosome 8 - one of the chains of DNA that house genes within a cell. Scientists have long known that part of chromosome 8 is missing in cancer cells.

Dr Edwards and colleagues specifically looked at breast cancer tumours but believe the gene is also linked to other cancers.

He said: ‘In every case that we looked at where a big chunk of chromosome 8 had been lost, at least part of the gene was lost. The gene was effectively ‘turned off’ in a lot of breast cancers.

‘If we have found the gene that is lost on chromosome 8 and we know that some other cancers also lose that bit of chromosome 8, then it is logical that it is the same gene.

‘We have got strong evidence that the gene is implicated in breast cancer but we have no reason to think it’s not the same for other cancers, including prostate and colon cancer.’

The latest research was published in the journal Oncogene and funded by Breast Cancer Campaign and Cancer Research UK.

Arlene Wilkie, of Breast Cancer Campaign, said: ‘This research is a major step forward in understanding the genetics of cancer.’

By David Derbyshire
dailymail.co.uk/

RELATED STORIES:
African-American women with advanced breast cancer often forego vital treatment   Contrast agent puts new light on diagnosing breast cancer   Preschool diet linked to cancer risk   Stress Linked To How Aggressive A Breast Cancer Might Be   Breast reduction surgery may uncover cancer risk   Breast cancer and heart disease may have common roots   Americans mixed on adequacy of cancer screenings: poll   Breast cancer screening may fuel over diagnosis   Mammograms on the rise for foreign-born women living in the US   Time interval from diagnosis to treatment of breast cancer at an NCI Comprehensive Cancer Center   UC Davis researchers use heated nanoprobes to destroy breast cancer cells in mice   Breast Implants Are Most Popular Form of Plastic Surgery   Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers   Red wine ingredient resveratrol stops breast cancer growth   Screening May Eventually Reduce Additional Breast Surgery   Expanding cell girth indicates seriousness of breast cancer   Breast cancer cells recycle to escape death by hormonal therapy   Hybrid vaccine demonstrates potential to prevent breast cancer recurrence   Breasts that are uneven appearance could be a predictor of breast cancer   Cell movement provides clues to aggressive breast cancer   Breast Cancer Patients With High Risk Gene Diagnosed Six Years Earlier Than Generation Before   Women new to HT had no increased risk of breast cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]